Clearside Biomedical CLSD Stock
Clearside Biomedical Price Chart
Clearside Biomedical CLSD Financial and Trading Overview
| Clearside Biomedical stock price | 0.41 USD |
| Previous Close | 0.41 USD |
| Open | 0.57 USD |
| Bid | 0.85 USD x 100 |
| Ask | 0.49 USD x 100 |
| Day's Range | 0.41 - 0.41 USD |
| 52 Week Range | 0.31 - 17.1 USD |
| Volume | 2.05M USD |
| Avg. Volume | 264.4K USD |
| Market Cap | 2.15M USD |
| Beta (5Y Monthly) | 1.787 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.11 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60 USD |
CLSD Valuation Measures
| Enterprise Value | 57.06M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.82 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.6446224 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 17.141 |
| Enterprise Value/EBITDA | -2.522 |
Trading Information
Clearside Biomedical Stock Price History
| Beta (5Y Monthly) | 1.787 |
| 52-Week Change | -94.32% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 17.1 USD |
| 52 Week Low | 0.31 USD |
| 50-Day Moving Average | 2.87 USD |
| 200-Day Moving Average | 8.22 USD |
CLSD Share Statistics
| Avg. Volume (3 month) | 264.4K USD |
| Avg. Daily Volume (10-Days) | 265.6K USD |
| Shares Outstanding | 5.23M |
| Float | 4.54M |
| Short Ratio | 3.86 |
| % Held by Insiders | 12.88% |
| % Held by Institutions | 13.67% |
| Shares Short | 141.01K |
| Short % of Float | 2.74% |
| Short % of Shares Outstanding | 2.68% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3502.48% |
| Gross Margin | 88.07% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.34% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 3.33M USD |
| Revenue Per Share (ttm) | 0.65 USD |
| Quarterly Revenue Growth (yoy) | -80.60% |
| Gross Profit (ttm) | 2.93M USD |
| EBITDA | -22630000 USD |
| Net Income Avi to Common (ttm) | -25996000 USD |
| Diluted EPS (ttm) | -5.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.8M USD |
| Total Cash Per Share (mrq) | 1.3 USD |
| Total Debt (mrq) | 61.61M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.98 |
| Book Value Per Share (mrq) | -10.308 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21293000 USD |
| Levered Free Cash Flow (ttm) | -20525250 USD |
Profile of Clearside Biomedical
| Country | United States |
| State | GA |
| City | Alpharetta |
| Address | 900 North Point Parkway |
| ZIP | 30005 |
| Phone | 678 270 3631 |
| Website | https://clearsidebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. On November 23, 2025, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For Clearside Biomedical Stock
What is a current CLSD stock price?
Clearside Biomedical CLSD stock price today per share is 0.41 USD.
How to purchase Clearside Biomedical stock?
You can buy CLSD shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Clearside Biomedical?
The stock symbol or ticker of Clearside Biomedical is CLSD.
Which industry does the Clearside Biomedical company belong to?
The Clearside Biomedical industry is Biotechnology.
How many shares does Clearside Biomedical have in circulation?
The max supply of Clearside Biomedical shares is 5.23M.
What is Clearside Biomedical Price to Earnings Ratio (PE Ratio)?
Clearside Biomedical PE Ratio is now.
What was Clearside Biomedical earnings per share over the trailing 12 months (TTM)?
Clearside Biomedical EPS is -5.11 USD over the trailing 12 months.
Which sector does the Clearside Biomedical company belong to?
The Clearside Biomedical sector is Healthcare.
Clearside Biomedical CLSD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26302.18 USD — |
+0.75
|
1.4B USD — | 26177.52 USD — | 26316.81 USD — | — - | 1.4B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2305.4 USD — |
+0.21
|
— — | 2292.63 USD — | 2311.92 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6493.2 USD — |
-0.36
|
— — | 6454.97 USD — | 6503.93 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1242.03 USD — |
+0.06
|
— — | 1233.72 USD — | 1242.6 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}